1. Medtech Insight
  2. >>Business
  3. >>Deals

Verily And iRhythm Agree To Collaborate On Atrial Fibrillation

 
• By Reed Miller

Verily Life Sciences and iRhythm Technologies have agreed to co-develop technology for screening, diagnosing and managing patients with atrial fibrillation, combining iRhythm’s artificial intelligence system for diagnosing arrhythmias with Verily’s health data analytics technology.

Working-together
• Source: shutterstock.com

Verily Life Sciences LLC and iRhythm Technologies Inc. have agreed to work together on technology for the diagnosis and management of atrial fibrillation.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business